Biden warns 'this is not a time to relax' as COVID-19 cases decline

President Biden is urging Americans not to let their guards down as COVID-19 cases decline in the United States, warning they still "could go back up."
Biden spoke during an event on Thursday celebrating that 50 million COVID-19 vaccine doses have been administered in the country since he took office, halfway to the administration's goal of 100 million doses in his first 100 days. But while the president hailed this milestone, he still cautioned against declaring premature victory in the pandemic.
"While COVID-19 vaccinations are up, COVID cases and hospitalizations are coming down," Biden said. "But I need to be honest with you: cases and hospitalizations could go back up with new variants as they emerge. So I want to make something really very clear: this is not a time to relax."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Biden urged Americans to continue to wash their hands, practice social distancing, and "for God's sake, wear a mask," as "the worst thing we could do now is let our guard down."
"This is not a victory lap," Biden went on to say. "Everything is not fixed. We have a long way to go."
The vaccination event came after the Food and Drug Administration on Wednesday confirmed that Johnson & Johnson's COVID-19 vaccine candidate is safe and effective, potentially clearing the way for it to be approved for emergency use by this weekend. Biden said Thursday that should the FDA approve this third vaccine, "we have a plan to roll it out as quickly as Johnson & Johnson can make it." Brendan Morrow
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Ukraine: where do Trump's loyalties really lie?
Today's Big Question 'Extraordinary pivot' by US president – driven by personal, ideological and strategic factors – has 'upended decades of hawkish foreign policy toward Russia'
By Elliott Goat, The Week UK Published
-
Should we give 'gentle parenting' a time out?
Talking Point Popular, empathy-heavy parenting technique facing a stern ticking off
By Abby Wilson Published
-
The world's best river cruises
The Week Recommends From the Danube to the Nile, these are the most scenic rivers to explore by boat
By Irenie Forshaw, The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published